The abnormal expression of ANXA3 is correlated with the development, occurrence, metastasis and drug resistance of cancers (Park et al., 2005; Harashima et al., 2008; Bandorowicz-Pikuła et al., 2012). Here, ANXA3 is linked to cancer.